Sisa, I., Noblecilla, E., & Orozco, F. (2021). Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs. Lancet.
シカゴスタイル引用形Sisa, Ivan, Estefania Noblecilla, , Fadya Orozco. "Rationale to Continue Approving Placebo-controlled COVID-19 Vaccine Trials in LMICs." Lancet 2021.
MLA引用形式Sisa, Ivan, Estefania Noblecilla, , Fadya Orozco. "Rationale to Continue Approving Placebo-controlled COVID-19 Vaccine Trials in LMICs." Lancet 2021.
警告: この引用は必ずしも正確ではありません.